52 Indians Arrested In US For "Illegal Immigration"

Agencies
June 20, 2018

Washington, Jun 20:  A group of 52 Indians, mostly Sikhs, has been held at a detention centre in the US State of Oregon for being part of a large contingent of illegal immigrants seeking asylum, an American lawmaker has said.

The Indians form the largest group of detainees in the total 123 illegal immigrants being held at a facility in Sheridan.

The detention centre was recently visited by a group of Democratic lawmakers from the Oregon State, who later told the media about the alleged inhuman condition of the illegal immigrants. The immigrants are seeking asylum in the US.

The detainees from India is the largest group of detainees being held in Sheridan, wrote Congresswoman Suzanne Bonamici on her blog post. She along with several other Democratic lawmakers from the State visited the detention centre Saturday.

"Through our Punjabi translator, we learned that these men were planning to request asylum because they faced severe religious persecution in India. Most are Sikh or Christian. Instead they were incarcerated in a federal prison," she said.

"They said they came to the United States for religious freedom, but they felt as if they were 'going crazy' because they are being confined in small cells for up to 22 hours a day," the Congresswoman said.

The Indian detainees pointed out that the other non-immigrant prisoners get far more time out of cells, she said.

Most of the detainees at the federal facility are asking for asylum because they experienced violence or persecution in their home countries, Ms Bonamici said.

Several had travelled to the border with a wife and a child or children; none knew where their family members are, she said.

"This is a shameful hour in US history. I don't care what your stance on immigration is, no one should favour ripping children out of their parents' arms ...." Democratic Congressman Earl Blumenauer told reporters after visiting the detention center.

He alleged that President Donald Trump and Attorney General Jeff Sessions have doubled down on their anti-immigrant, xenophobic agenda with the administration's new "zero tolerance" policy on immigration.

"The administration is criminalising families who are fleeing abuse and violence and separating children as ICE detains or deports their parents," he said in a statement.

According to the local daily 'The Oregonian', of the total detainees, 52 have identified themselves as Sikhs or Christians from India.

They alleged that they fled from their country because of religious persecution from the Hindu majority. The Indians told the delegation that their Hindi and Punjabi translators were the first outsiders they've been able to talk to since they were imprisoned weeks ago, the daily reported.

The Congressional delegation included Senators Jeff Merkley and Ron Wyden.

"As the child of parents whose families found refuge in America from the terrors of Nazi Germany, I strongly believe Donald Trump's cruel and callous treatment of human beings seeking asylum flies in the face of America's core humanitarian values," Mr Wyden said.

"Trump's choice of zero tolerance for the refugees we met today and for the others imprisoned around the country this Father's Day weekend makes zero sense and shows zero understanding of American values.

"What I saw and heard today highlights the urgency of reversing Trump's mean, dangerous and damaging actions - returning America to our unique role as a beacon of hope that welcomed our immigrant ancestors and creating the future we want for our children," he said.

These 123 detainees are among the more than 1,600 people that Immigration and Customs Enforcement (ICE) is holding in federal prisons across the US as it enforces Trump's "zero-tolerance policy" on immigration, the lawmakers said in a joint statement.

The men come from 16 different countries: Bangladesh, Brazil, Cameroon, China, El Salvador, Guatemala, Honduras, Mexico, India, Mauritania, Nepal, Peru and Russia, as well as from Congo and Eritrea, it said.

The Congressional delegation were told that that detainees are being held upwards for 23 hours a day with three men bunked in each cell. The prison does not have the resources to house ICE detainees alongside pre-trial inmates who are normally held in the facility.

The delegation was also told that incompatibility between BOP and ICE telephone systems was preventing ICE detainees at the BOP facility from accessing legal services.

According to lawmakers, the detainees described stress as they sit in cells day after day without knowing when they will get a hearing, or get a lawyer, or what comes next.

"Several men had been separated from their children, and experienced the added stress of not knowing what happened to their families.

"Under Trump's 'zero-tolerance policy', the men's children were taken away at the border - one man said an ICE official told him, 'it's not my choice; the decision came from above' - and the fathers still don't have any information about their location, condition or well-being," the lawmakers said.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
March 4,2020

Beijing/Zurich, Mar 4: China has approved the use of Swiss drugmaker Roche's anti-inflammation drug Actemra for patients who develop severe complications from the coronavirus as it urgently hunts for new ways to combat the deadly infection that is spreading worldwide.

China is hoping that some older drugs could stop severe cytokine release syndrome (CRS), or cytokine storms, an overreaction of the immune system which is considered a major factor behind catastrophic organ failure and death in some coronavirus patients.

Actemra, a biologic drug approved in 2010 in the United States for rheumatoid arthritis (RA), inhibits high Interleukin 6 (IL-6) protein levels that drive some inflammatory diseases.

China's National Health Commission said in treatment guidelines published online on Wednesday that Actemra can now be used to treat coronavirus patients with serious lung damage and high IL-6 levels.

Separately, researchers in the country are testing Actemra, known generically as tocilizumab, in a clinical trial expected to include 188 coronavirus patients and running until May 10.

Roche, which donated 14 million yuan ($2.02 million) worth of Actemra during February, said the trial was initiated independently by a third party with the aim of exploring the efficacy and safety of the drug in coronavirus patients with CRS.

It added that there was currently no published clinical trial data on the drug's safety or efficacy against the virus.

More than 3,000 people have died and 93,000 have been infected by the novel coronavirus thought to have originated in Wuhan, China, before spreading to around 90 countries including the United States, Italy, Switzerland, France and Germany.

The Swiss company, for which China is its No. 2 market behind the United States, also makes diagnostic gear to detect the coronavirus.

Since Actemra's approval a decade ago, it has become a go-to drug against other inflammatory conditions, including cytokine storms in cancer patients receiving cell therapies from Novartis and Gilead Sciences.

In 2012 it helped save the life of a young U.S. girl, the first child to be treated for leukaemia with Novatis' Kymriah, from a post-treatment rush of IL-6.

Priced at between $20-30,000 annually for RA according to SSR Health, Roche's medicine is also used for rare juvenile arthritis and giant cell arteritis, or inflammation of the blood vessels.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
April 11,2020

Apr 11: The number of global coronavirus deaths has increased to 102,753, while the total number of cases worldwide has surpassed 1.6 million, according to the latest update by the Washington-based Johns Hopkins University.

As of Saturday morning, the overall number of infections increased to 1,698,416, while the tally of those who recovered from the deadly disease stood at 376,677, according to the varsity's Center for Systems Science and Engineering (CSSE).

In terms of cases, the US had the highest in the world at 501,301, followed by Spain 158,273, Italy 147,577 and France 125,931.

Italy accounted for the highest death toll at 18,849, with the US in the second place with 18,769 fatalities.

Other countries with more than 10,000 deaths include Spain (16,081) and France (13,197).

Although the pandemic originated in China last December, it now only accounts for 3,343 deaths with 83,003 confirmed cases.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
March 28,2020

Washington, Mar 28: A US-based lab has unveiled a portable test that can tell if someone has COVID-19 in as little as five minutes, it said in a statement Friday.

Abbot Laboratories said the US Food and Drug Administration (FDA) had given it emergency authorization to begin making the test available to healthcare providers as early as next week.

The test, which is the size of a small toaster and uses molecular technology, also shows negative results within 13 minutes, the company said in a press statement.

"The COVID-19 pandemic will be fought on multiple fronts, and a portable molecular test that offers results in minutes adds to the broad range of diagnostic solutions needed to combat this virus," said Abbot president and chief operating officer Robert Ford.

The test's small size means it can be deployed outside the "traditional four walls of a hospital in outbreak hotspots," Ford said, and Abbott is working with the FDA to send it to virus epicenters.

The test has not been cleared or approved by the FDA, and has only been authorized for emergency use by approved labs and healthcare providers, the company said.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.